Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

EMA Product Specific GL [Regulatives / Guidelines]

posted by mmw – India, 2017-07-14 16:50 (2268 d 03:02 ago) – Posting: # 17548
Views: 9,212

Dear all,

EMA adopted a new batch of product specific guidances. Published on 10/07/2017:

Crizotinib
Elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil
Elvitegravir
Emtricitabine, rilpivirine, tenofovir, disoproxil
Vortioxetine

Thanks

MMW

Complete thread:

EMA Product Specific GLmmw 2017-07-14 14:50 [Regulatives / Guidelines]
- EMA Product Specific GL Helmut 2017-07-28 12:40
  - tlag‽ Helmut 2017-08-03 17:47
    - tlag‽ BRB 2017-12-20 16:25
      - tlag‽ Helmut 2017-12-21 13:28
        
        tlag‽ nobody 2017-12-21 14:17
        
        tlag‽ Helmut 2017-12-21 14:43
        
        tlag‽ nobody 2017-12-21 15:18
        
        tlag‽ Helmut 2017-12-21 15:41
        
        tlag‽ nobody 2017-12-21 15:57

Admin contact
22,763 posts in 4,775 threads, 1,627 registered users;
20 visitors (0 registered, 20 guests [including 7 identified bots]).
Forum time: 19:53 CEST (Europe/Vienna)

A little Learning is a dang’rous Thing;
Drink deep, or taste not the Pierian Spring:
There shallow Draughts intoxicate the Brain,
And drinking largely sobers us again. Alexander Pope

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz